“Quality and Regulatory excellence means putting patients first and making the very best product available for every patient we serve. I am proud to join the team at Genomic Health in delivering personalized cancer treatment with the use of cutting-edge diagnostics and services. There is nothing more personally or professionally gratifying than helping physicians improve cancer outcomes for hundreds of thousands of patients around the world each year. Through our work to revolutionize the treatment of cancer throughout the patient journey, we all benefit from the way Genomic Health is transforming cancer care.”
David Hanlon joined Genomic Health in 2019 as Senior Vice President, Regulatory Affairs and Quality Assurance bringing extensive experience and a passion for patient care spanning nearly four decades at pharmaceutical, medical device and in vitro diagnostic companies. To advance the company’s efforts to offer multiple platforms in markets around the world, David leads Regulatory and Quality teams supporting the company’s clinical laboratory and critical business functions. Prior to joining Genomic Health, David held various global leadership positions at Cardinal Health, Terumo, Bausch and Lomb, Fisher Diagnostics and Wyeth where he was responsible for Regulatory submissions, FDA compliance, site manufacturing, deployment of global quality systems and integration of business acquisitions. David holds a Bachelor of Arts degree in Biology and Chemistry from Westmar University and an MBA from Shenandoah University.
Oncotype DX My Colon Cancer Coach